Open Your FREE Demat Account Now!

N/A
indicator

Nifty500 Healthcare Index

1D
1M
3M
6M
1Y
5Y
empty graph

Nifty500 Healthcare Index Performance

Low

₹20,712.05

High

₹20,931.15

52 Week Range

Low

₹17,164.05

High

₹22,125.15

Previous Close ₹20,828.90
Day's Range ₹20,712.05 - ₹20,931.15
Open ₹20,860.50
52 Week Range ₹17,164.05 - ₹22,125.15
Volume 2,54,56,893

Nifty500 Healthcare Index Companies

Company Name LTP (₹) Change (₹) Sector
Cipla Ltd. 1338.10 Arrow 2.60 (0.19%) Healthcare
Dr. Reddy's Laboratories Ltd. 1201.70 Arrow -1.30 (-0.11%) Healthcare
Lupin Ltd. 2024.10 Arrow 13.10 (0.65%) Healthcare
Torrent Pharmaceuticals Ltd. 4766.80 Arrow -5.20 (-0.11%) Healthcare
Abbott India Ltd. 26070.00 Arrow -170.00 (-0.65%) Healthcare
Glaxosmithkline Pharmaceuticals Ltd. 2734.20 Arrow 1.40 (0.05%) Healthcare
Apollo Hospitals Enterprise Ltd. 7880.50 Arrow -104.50 (-1.31%) Healthcare
Ipca Laboratories Ltd. 1937.80 Arrow -13.50 (-0.69%) Healthcare
Neuland Laboratories Ltd. 21515.00 Arrow -360.00 (-1.65%) Healthcare
Sun Pharmaceutical Industries Ltd. 1783.70 Arrow 4.00 (0.22%) Healthcare

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 22719.35 26373.20 22182.55
Nifty IT 27982.6 40301.40 25699.10
Nifty Next 50 69830.6 75000.40 59896.10
NIFTY50 USD Index 8166.85 10443.40 7839.85
Nifty Bank 55172.95 61764.85 49954.85
NIFTY Midcap 100 59620.8 64450.90 52032.85
Nifty 500 22144.1 24144.20 20385.65
Nifty Midcap 50 17073.85 18500.95 14804.55
Nifty 100 23824.15 26975.15 22720.45
Nifty FMCG 44716.55 57445.20 43442.30

Latest News

Oct
6
2026
EQUITY Posted on Oct 6th 2026

Lupin informs about press release

Lupin has informed that it enclosed a Press Release titled ‘Lupin Launches Formoflo-G® MDI, World’s First Fixed-dose Triple Combination Drug for COPD Management’.
The above information is a part of company’s filings submitted to BSE. 
Read More
Oct
6
2026
EQUITY Posted on Oct 6th 2026

Glenmark Pharmaceuticals informs about media release

Glenmark Pharmaceuticals has informed that, Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Adapalene Gel USP, 0.1% (OTC) in new pump packs. Glenmark’s Adapalene Gel USP, 0.1% can be compared to the active ingredient of Differin®2 Gel, 0.1%. According to Nielsen® syndicated data for the latest 52-week period ending September 5, 2026, the Differin® Gel, 0.1% (OTC) market3 achieved annual sales of approximately $45.8 million*. The company has attached media release in this regard. 
The above information is a part of company’s filings submitted to BSE. 
Read More
Oct
3
2026
EQUITY Posted on Oct 3rd 2026

Aurobindo Pharma informs about acquisition

Aurobindo Pharma has informed that this is with refer to letters dated July 23, 2026, September 12, 2026 and October 01, 2026, informing that Apitoria Pharma Private Limited (Apitoria), a wholly owned subsidiary of the Company, is acquiring the Contract Research Services business of A1 Biochem Group. A1 Biochem USA Inc (A1 USA Inc), which is a wholly owned subsidiary of A1 Biochem Labs (India) Private Limited (A1 Labs India), has acquired 100% ownership of A1 Biochem Labs LLC (A1 Labs LLC) in accordance with the terms of the Definitive Agreements entered into for the acquisition of A1 Biochem Group. A1 Labs LLC is operating from USA and will now be a step-down subsidiary of A1 Labs India. The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, is attached as Annexure A.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
3
2026
EQUITY Posted on Oct 3rd 2026

Abbott India informs about newspaper advertisement

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, and in compliance with the Circular issued by Securities and Exchange Board of India dated January 30, 2026, Abbott India has informed that it enclosed the newspaper advertisement, pertaining to the opening of special window for transfer and dematerialization of physical securities, published in the Business Standard (All Editions) and Loksatta today, Friday, October 2, 2026.

The above information is a part of company’s filings submitted to BSE.

Read More
Oct
1
2026
EQUITY Posted on Oct 1st 2026

Sai Life Sciences submits board meeting intimation

Sai Life Sciences has informed that pursuant to Regulation 29(1) of the SEBI Listing Regulations, a meeting of Board of Directors of the Company is scheduled to be held on Thursday, 05th November 2026, to consider and approve: 1. The standalone and consolidated unaudited financial results of the Company for the second quarter and half year ended September 30, 2026; and 2. Other corporate matters. As informed by our communication letter dated 28th September 2026, the trading window for dealing in the securities of the Company was closed for all designated persons and their immediate relatives from 01st October 2026 and shall remain closed till 48 hours after the announcement of financials results i.e. up to 07th November 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of NFT500HEALTH index?

The previous close of NFT500HEALTH index is ₹20894.75 as of 2026-10-06.

The total volume of NFT500HEALTH index is 25456893.00 as of 2026-10-06.

The percentage change in value of NFT500HEALTH index is 0.32% as of 2026-10-06.

The absolute increase in NFT500HEALTH index value since the previous trading day is ₹65.85 as of 2026-10-06.

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More

People Also Ask

What defines the Nifty 500 Healthcare Index?

The Nifty 500 Healthcare Index is a sectoral index that tracks selected healthcare companies from the Nifty 500 universe. It represents listed businesses across healthcare delivery, pharmaceuticals, diagnostics, biotechnology, medical services, and related segments.

Companies are selected from healthcare-sector stocks within the Nifty 500 universe based on NSE Indices' methodology and industry classification. The index is reviewed periodically in accordance with the index maintenance methodology.

The Nifty 500 Healthcare Index is calculated using the free-float market capitalisation method. This approach considers only publicly available shares while assigning weights to eligible healthcare companies within the index.

The Nifty 500 Healthcare Index includes companies from pharmaceuticals, hospitals, diagnostics, biotechnology, healthcare services, medical equipment, and related healthcare businesses listed within the broader Nifty 500 universe.

Yes, hospitals, diagnostics, and pharmaceutical companies may be part of the Nifty 500 Healthcare Index if they meet the index provider’s eligibility rules. The index is designed to capture different areas of India’s healthcare sector.

The Nifty 500 Healthcare Index measures the performance of healthcare-sector companies included in the Nifty 500 universe. It reflects the market performance of listed companies engaged in areas such as pharmaceuticals, hospitals, diagnostics, biotechnology, medical equipment, and other healthcare-related businesses.

The Nifty 500 Healthcare Index is reviewed and rebalanced periodically in accordance with NSE Indices' index maintenance methodology. The review helps ensure that the index continues to reflect eligible healthcare companies within the Nifty 500 universe.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore